Want to see AUPH full AI Analyst Report?
Aurinia Pharmaceuticals (AUPH) Ownership Overview
12.79% Insiders
4.56% Mutual Funds
0.46% Other Institutional Investors
7.37% ETFs
74.82% Public Companies and
Individual Investors
The ownership structure of Aurinia Pharmaceuticals (AUPH) stock is a mix of institutional, retail, and individual investors. Approximately 12.39% of the company’s stock is owned by Institutional Investors, 12.79% is owned by Insiders, and 74.82% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Sep 11, 2026 | xxxxxxxxxxxxx | $190427 | |
Jun 02, 2026 | xxxxxxxxxxxxx | $12455227 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,044,106 | Insider | 9.80% | 222,271,566 | |
| 5,790,634 | Institution | 4.35% | 98,672,403 | |
| 1,864,706 | Institution | 1.40% | 31,774,590 | |
| 1,744,866 | Insider | 1.31% | 29,732,517 | |
| 1,269,557 | Institution | 0.95% | 21,633,251 | |
| 1,266,444 | Institution | 0.95% | 21,580,206 | |
| 710,464 | Institution | 0.53% | 12,106,307 | |
| 662,900 | Insider | 0.50% | 11,295,816 | |
| 588,848 | Insider | 0.44% | 10,033,970 | |
| 569,952 | Institution | 0.43% | 9,711,982 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,864,706 | Institution | 1.40% | 31,774,590 | |
| 1,269,557 | Institution | 0.95% | 21,633,251 | |
| 710,464 | Institution | 0.53% | 12,106,307 | |
| 431,177 | Institution | 0.32% | 7,347,256 | |
| 336,741 | Institution | 0.25% | 5,738,067 | |
| 172,372 | Institution | 0.13% | 2,937,219 | |
| 111,924 | Institution | 0.08% | 1,907,185 | |
| 92,212 | Institution | 0.07% | 1,571,292 | |
| 84,000 | Institution | 0.06% | 1,431,360 | |
| 80,526 | Institution | 0.06% | 1,372,163 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,998,030 | Institution | 2.25% | 51,086,431 | |
| 1,115,293 | Institution | 0.84% | 19,004,593 | |
| 895,089 | Institution | 0.67% | 15,252,317 | |
| 693,441 | Institution | 0.52% | 11,230,277 | |
| 469,571 | Institution | 0.35% | 7,916,967 | |
| 314,458 | Institution | 0.24% | 5,092,647 | |
| 236,160 | Institution | 0.18% | 3,981,658 | |
| 200,823 | Institution | 0.15% | 3,385,876 | |
| 192,018 | Institution | 0.14% | 3,237,423 | |
| 165,904 | Institution | 0.12% | 2,797,141 |
FAQ
Who Owns Aurinia Pharmaceuticals (AUPH)?
According to the latest TipRanks data, approximately 0.46% of the company's stock is held by institutional investors, 12.79% is held by insiders, and 74.82% is held by retail investors.
What percentage of Aurinia Pharmaceuticals (AUPH) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.46% of Aurinia Pharmaceuticals (AUPH) stock is held by institutional investors.
What percentage of Aurinia Pharmaceuticals (AUPH) stock is held by retail investors?
According to the latest TipRanks data, approximately 74.82% of Aurinia Pharmaceuticals (AUPH) stock is held by retail investors.
Who owns the most shares of Aurinia Pharmaceuticals (AUPH)?
Kevin Tang owns the most shares of Aurinia Pharmaceuticals (AUPH).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.